文献速递眼底病与葡萄膜炎

玻璃体腔抗VEGF注射后眼内炎:未做微生物培养患眼的结局

Endophthalmitis After Intravitreal Anti-Vascular Endothelial Factor Injections: Outcomes of Eyes Managed Without Microbiologic Cultures.
PubMed 文献 · Am J Ophthalmol · 2021-08-27

回顾性单中心比较队列研究纳入2013年7月至2019年9月玻璃体腔抗VEGF注射后眼内炎165例,培养组119例(72%)与无培养组46例(28%)。6个月随访时无培养组平均视力下降2.5行,少于培养组的5.5行(P=.017),提示无微生物培养条件下直接玻璃体腔抗生素治疗可能可接受。

要点

  • 无培养组6个月平均视力下降2.5行,培养组为5.5行,差异有统计学意义(P=.017)。
  • 两组需后续玻璃体切割术比例无显著差异:培养组24%(29/119)对无培养组15%(7/46),P=.29。
  • 培养组5%(6/119)出现继发性视网膜脱离,无培养组无此事件(P=.143)。

核心结论

  • 当无法进行微生物培养时,玻璃体腔注射抗生素而不做微生物培养治疗注射后眼内炎可能是可接受的治疗策略。

研究设计与样本

  • 回顾性、单中心、比较队列研究,纳入2013年7月1日至2019年9月1日所有注射后眼内炎患眼。
  • 培养组定义为玻璃体腔抗生素治疗并送检房水或玻璃体微生物采样,无培养组定义为立即玻璃体腔抗生素注射并行前房穿刺但不送微生物采样。
  • 共纳入165例眼内炎病例,培养组119例(72%),无培养组46例(28%)。

主要发现

  • 眼内炎就诊时培养组平均logMAR视力1.98(约20/1900),无培养组1.90(约20/1600),P=.589。
  • 6个月随访时培养组平均较基线视力下降5.5行,无培养组下降2.5行,P=.017。
  • 培养组119眼中29眼(24%)需后续玻璃体切割术,无培养组46眼中7眼(15%),P=.29。
  • 培养组119眼中6眼(5%)发生继发性视网膜脱离,无培养组无发生,P=.143。

关键数值与推荐

  • 研究主要结局指标为视力、视网膜脱离发生率及需额外手术情况。
  • 培养组与无培养组在就诊视力、后续玻璃体切割术比例及视网膜脱离发生率上无显著差异。
  • 6个月视力下降行数在两组间差异有统计学意义(P=.017),无培养组视力下降更少。

临床怎么用

  • 在无微生物培养设施条件下,对玻璃体腔抗VEGF注射后眼内炎可考虑直接玻璃体腔抗生素治疗而不送培养。
  • 该策略下6个月视力下降更少,且未增加视网膜脱离或后续玻璃体切割术风险。

局限性

  • 回顾性、单中心研究设计可能引入选择偏倚。
  • 无培养组样本量较小(46眼),部分比较可能统计效能不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate outcomes of eyes that developed endophthalmitis after intravitreal anti-vascular endothelial growth factor injections that were managed without microbiologic cultures. DESIGN: Retrospective, single-center, comparative cohort study. METHODS: We included all eyes with postinjection endophthalmitis from July 1, 2013, to September 1, 2019. Endophthalmitis cases were divided into the culture group if treated with intravitreal antibiotics and a vitreous or aqueous tap sent for microbiologic sampling or into the no culture group if treated with immediate injection of intravitreal antibiotics with an anterior chamber paracentesis that was not sent for microbiologic sampling. The main outcome measures were visual acuity, the incidence of retinal detachment, and the need for additional procedures. RESULTS: Of 165 endophthalmitis cases identified, 119 (72%) were in the culture group and 46 (28%) were in the no culture group. At endophthalmitis presentation, eyes in the culture group had a mean logMAR VA of 1.98 (∼20/1900) compared with 1.90 (∼20/1600) for eyes in the no culture group (P = .589). At the 6-month follow-up, the mean vision loss was 5.5 lines lost from baseline for the culture group compared with 2.5 lines lost for the no culture group (P = .017). Eyes in the culture group required a subsequent pars plana vitrectomy in 29 of 119 cases (24%) compared with 7 of 46 cases (15%) in the no culture group (P = .29). Six of 119 eyes (5%) in the culture group developed secondary retinal detachments compared with none in the no culture group (P = .143). CONCLUSIONS: When access to microbiologic facility is not available, the management of postinjection endophthalmitis using intravitreal antibiotics without microbiologic cultures may be an acceptable treatment strategy.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Patel SN, Cai LZ, Mahmoudzadeh R, et al. Endophthalmitis After Intravitreal Anti-Vascular Endothelial Factor Injections: Outcomes of Eyes Managed Without Microbiologic Cultures. Am J Ophthalmol. 2021. PMID: 34461083. doi:10.1016/j.ajo.2021.08.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。